Compare MLKN & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLKN | INSP |
|---|---|---|
| Founded | 1905 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 1994 | 2018 |
| Metric | MLKN | INSP |
|---|---|---|
| Price | $22.16 | $62.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $94.00 |
| AVG Volume (30 Days) | ★ 441.0K | 399.3K |
| Earning Date | 03-25-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | ★ 344.44 | 179.43 |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $3,841,700,000.00 | $82,050,000.00 |
| Revenue This Year | $5.94 | $8.02 |
| Revenue Next Year | $3.78 | $8.11 |
| P/E Ratio | $17.36 | ★ N/A |
| Revenue Growth | 4.68 | ★ 62.18 |
| 52 Week Low | $13.77 | $38.91 |
| 52 Week High | $24.71 | $147.03 |
| Indicator | MLKN | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 59.82 |
| Support Level | $18.05 | $56.50 |
| Resistance Level | $23.18 | $66.21 |
| Average True Range (ATR) | 0.75 | 2.64 |
| MACD | -0.21 | -0.21 |
| Stochastic Oscillator | 20.54 | 71.00 |
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.